Sample Simulacrum underlying tables

• Published by: Public Health England
• Last updated: 22 November 2018
• Topic: Health
• Licence: Open Government Licence

Summary

The Simulacrum (https://simulacrum.healthdatainsight.org.uk) is a synthetic dataset populated entirely with simulated cancer patients. In order to enhance public understanding of the methodology used to create the simulacrum, a sample of the underlying data tables was released, along with an explanatory document (see additional resources).

Data within these tables shows incidences of simulation of underlying cause of death code (coded in ICD 10), the stage of the tumour (coded in UICC TNM) and the dose of chemotherapy prescribed to the patient (doses are recorded in mg or other applicable units depending on the drug), for some patients whose first tumours were breast and lung.

No specific disclosure controls are applied, as all counts are at all England level for three years of grouped data 2013-2015, and the denominator populations are large enough to pass the anonymisation standard for Health and Social Care data.

More from this publisher

All datasets from Public Health England

Related datasets

• Cancer Registration: Epidemiology of lung cancer tumours in England 2009 to 2013
• Cancer Registration: Frequency of lung Cancer tumours Diagnosed in 2015-2016 by CCG and Route to Diagnosis
• Cancer Registration: Epidemiology of Renal Cancer (1985-2016)
• Cancer Registration: Frequency counts of cancer patients in receipt of radiotherapy between 1 April 2016 and 31 March 2017

Search

Data links

Link to the data	Format	File added	Data preview
26 Distribution Dose per Drug Administration Trastuzumab Breast	CSV	22 November 2018	Preview
27 Distribution Drug Group FEC + Docetaxel Breast	CSV	22 November 2018	Preview
28 Cluster Drug Group for Dose per Drug Administration FEC + Docetaxel Breast	CSV	22 November 2018	Preview
29 Distribution Dose per Drug Administration FEC + Docetaxel Breast	CSV	22 November 2018	Preview
1 Distribution Death Location Breast	CSV	22 November 2018	Preview
2 Cluster Death Location for Underlying Cause of Death Breast	CSV	22 November 2018	Preview
3 Distribution Underlying Cause of Death Breast	CSV	22 November 2018	Preview
4 Distribution Death Location Lung	CSV	22 November 2018	Preview
5 Cluster Death Location for Underlying Cause of Death Lung	CSV	22 November 2018	Preview
6 Distribution Underlying Cause of Death Lung	CSV	22 November 2018	Preview
7 Distribution Summary stage at diagnosis Breast	CSV	22 November 2018	Preview
8 Cluster Summary stage at diagnosis for N stage at diagnosis Breast	CSV	22 November 2018	Preview
9 Distribution N stage at diagnosis Breast	CSV	22 November 2018	Preview
10 Cluster Summary stage at diagnosis for T stage at diagnosis Breast	CSV	22 November 2018	Preview
11 Cluster N stage at diagnosis for T stage at diagnosis Breast	CSV	22 November 2018	Preview
12 Distribution T stage at diagnosis Breast	CSV	22 November 2018	Preview
13 Distribution M stage at diagnosis Lung	CSV	22 November 2018	Preview
14 Cluster M stage at diagnosis for Summary stage at diagnosis Lung	CSV	22 November 2018	Preview
15 Distribution Summary stage at diagnosis Lung	CSV	22 November 2018	Preview
16 Cluster Summary stage at diagnosis for T stage at diagnosis Lung	CSV	22 November 2018	Preview
17 Cluster M stage at diagnosis for T stage at diagnosis Lung	CSV	22 November 2018	Preview
18 Distribution T stage at diagnosis Lung	CSV	22 November 2018	Preview
19 Cluster Summary stage at diagnosis for N stage at diagnosis Lung	CSV	22 November 2018	Preview
20 Cluster M stage at diagnosis for N stage at diagnosis Lung	CSV	22 November 2018	Preview
21 Distribution N stage at diagnosis Lung	CSV	22 November 2018	Preview
22 Cluster for Route of Drug Administration Trastuzumab Breast	CSV	22 November 2018	Preview
23 Distribution Route of Drug Administration Trastuzumab Breast	CSV	22 November 2018	Preview
24 Cluster Mapped Regimen for Dose per Drug Administration Trastuzumab Breast	CSV	22 November 2018	Preview
25 Cluster Route of Drug Administration for Dose per Drug Administration Trastuzumab Breast	CSV	22 November 2018	Preview

Supporting documents

Link to the document	Format	Date added
Document explaining the data	DOC	22 November 2018

Contact

Enquiries

Simulacrum team simulacrumenquiries@phe.gov.uk

Freedom of Information (FOI) requests

FOI FOI@phe.gov.uk https://www.gov.uk/government/organisations/public-health-england

Edit this dataset

You must have an account for this publisher on data.gov.uk to make any changes to a dataset.

Sign in